Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV000677520 | SCV000803030 | likely pathogenic | Mucopolysaccharidosis type 6 | 2018-01-01 | criteria provided, single submitter | curation | Frameshift variant(PVS1); Absent from GnomAD (PM2) |
Labcorp Genetics |
RCV000677520 | SCV003525801 | pathogenic | Mucopolysaccharidosis type 6 | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val80Trpfs*32) in the ARSB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 8125475). ClinVar contains an entry for this variant (Variation ID: 559744). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000677520 | SCV004202289 | pathogenic | Mucopolysaccharidosis type 6 | 2022-05-31 | criteria provided, single submitter | clinical testing |